The SCMP Group’s announcement was ambiguous about what was the target in the acquisition talks and calls to the group ... It was hit hard by a relaxation of Hong Kong Stock Exchange rules on company announcements in 2006. …
top 10 global stock exchanges (1997-2017*) Proceeds raised (US$b) Market share (%) Number of issues New York Hong Kong Nasdaq London Shanghai Tokyo …
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in developing, identifying, acquiring and bringing medicines that meet unmet medical needs. It focuses on gastroenterology, ophthalmology, and oncology …
Maxim Group’s target price would indicate a potential upside of 124.39% from the stock’s current price. Several other equities research analysts also recently commented on SCMP. ValuEngine downgraded shares of Sucampo …
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)‘s stock had its “buy” rating restated by stock analysts at Maxim Group in a note issued to investors on Tuesday. They currently have a $23.00 target price on the biopharmaceutical …
Sucampo Pharmaceuticals, Inc.(SCMP - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for SCMP broke …
ZACKS5mon
though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve …
HONG KONG, Feb 18 (Reuters) - SCMP Group Ltd, the publisher of Hong Kong's South China Morning Post newspaper, said on Monday it is in talks regarding the possible acquisition of a group of media companies in Hong Kong. The …
On Tuesday, February 9 the stock rating was initiated by UBS with "Buy". The firm earned "Buy" rating on Wednesday, April 20 by Mizuho. (NASDAQ:SCMP) has "Buy" rating given on Wednesday, August 2 by Maxim Group. Maxim …